Ortho VCs Are Getting Soft, But Still Show Spine

Private investors in orthopedic companies still are backing traditional and large joint companies, but soft tissue and biomaterials are drawing a solid total of early-stage capital.

This past month’s news of the monster private equity financings of Small Bone Innovations Inc. and ConforMIS Inc. drew a bright, white hot light on the state of venture investing in orthopedics start-ups. Does the $144 million committed to Small Bone Innovations, a mega start-up committed to the extremities (or small bone) sector, reflect broader investor interest in that increasingly interesting sector? [See Deal][See Deal] Likewise, what does $50 million put into in knee replacement company ConforMIS so far say about the entrepreneurial interest in the large but sleepy large joint sector? [See Deal] (See "SBI and ConforMIS Think and Act Globally In Search for Funds," this issue, for a detailed look at the two deals. Also see "SBI, ConforMIS Think and Act Globally in Search for Funds" - Medtech Insight, 1 July, 2009..)

A review of data in Elsevier’s Strategic Transactions database revealed that venture investors aren’t showing much interest in funding start-ups targeting the small bone arena where SBI is operating. But...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Roche Diagnostics Day 2025: ‘We Need To Become A Leader In Decentralized Testing’

 

Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.

BD To Shift China-Facing Production, Ramp Up US Output With $2.5B To Counter Tariff Blow

 
• By 

BD is accelerating transitions of product sourcing for China to avoid tariffs. Historically, products like Vacutainer were exported from Sumter, SC, to China, and Flush was shipped from Columbus, NE.

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

More from Business

Industry Execs Talk Tariff Turbulence During MD&M East

 

During MD&M East in Manhattan last week, a panel of experts discussed how the Trump administration’s trade policy is affecting manufacturing and offered some ideas on what manufacturers can do to help mitigate the chaos.

Bone Surgery Startup Surgify Medical Raises $7.9m

 

Surgify Medical’s selective drill tip, Surgify Halo, is “an obvious choice for surgeons,” said Boris Hofmann, head of ZEISS Ventures and lead investor in the company’s series A funding round.

German Bionic Launches ‘Strongest Exoskeleton To Date’

 

German Bionic’s new exoskeleton Exia helps healthcare practitioners, nurses, and other caregivers to lift and move patients by supporting muscle movement and reducing the risk of injury.